FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395273005: Product containing insulin aspart and insulin aspart protamine (medicinal product)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3522077017 Product containing insulin aspart and insulin aspart protamine (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3715293011 Insulin aspart protamine- and insulin aspart-containing product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
5250521000241115 produit contenant de l'insuline asparte et de l'insuline aspart protamine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing insulin aspart and insulin aspart protamine (medicinal product) Is a Product containing insulin aspart (medicinal product) true Inferred relationship Some
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pancreatic hormone false Inferred relationship Some
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Human insulin false Inferred relationship Some
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin aspart false Inferred relationship Some
Product containing insulin aspart and insulin aspart protamine (medicinal product) Is a Product containing biphasic insulin false Inferred relationship Some
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Short-acting insulin false Inferred relationship Some
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Biphasic insulin false Inferred relationship Some
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin aspart protamine (substance) true Inferred relationship Some 1
Product containing insulin aspart and insulin aspart protamine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Insulin aspart true Inferred relationship Some 2
Inbound Relationships Type Active Source Characteristic Refinability Group
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL Is a False Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL Is a False Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection cartridge 3mL Is a False Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection prefilled pen 3mL Is a False Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some
Insulin biphasic aspart 30/70 100units/mL injection solution 10mL vial Is a False Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some
Insulin biphasic aspart 50/50 100units/mL injection solution 3mL prefilled cartridge Is a False Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some
Insulin biphasic aspart 50/50 100units/mL injection solution 3mL prefilled syringe Is a False Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some
Insulin aspart and insulin aspart protamine only product Is a True Product containing insulin aspart and insulin aspart protamine (medicinal product) Inferred relationship Some

This concept is not in any reference sets

Back to Start